In today’s briefing:
- Mankind Pharma Pre-IPO – The Positives – Diverse Portfolio with Steady past Performance
- Broadcom Inc: New Test Solutions With Rohde & Schwarz & Other Drivers
- Juniper Networks: Agreement With Powerco & Other Developments
- Pre-IPO CanSino Biologics – 2022 Annual Results May Be Ugly as MCV4 Commercialization Hit a Snag
- GoDaddy Inc: Major Drivers, Financial Forecasts, DCF & Comparables Valuation, Key Risks (01/23)
- SunPower Corporation: Partnership With General Motors & Other Drivers
Mankind Pharma Pre-IPO – The Positives – Diverse Portfolio with Steady past Performance
- Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO.
- MP is a pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
- In this note, we talk about the positive aspects of the deal.
Broadcom Inc: New Test Solutions With Rohde & Schwarz & Other Drivers
- Broadcom delivered a strong result in the last quarter with revenues growing 21% year-on-year, surpassing Wall Street expectations.
- This growth was driven by the company’s strong partnerships and increased R&D investments that enabled accelerated adoption of its new-generation technologies.
- In the quarter, semiconductor solution revenue and infrastructure software revenue grew.
Juniper Networks: Agreement With Powerco & Other Developments
- Juniper’s stock has seen good upward momentum with its results around the corner.
- The company had delivered better-than-expected results in the last quarter with its total revenues as well as earnings exceeding Wall Street expectations.
- The cloud business of Juniper also delivered solid quarterly result with revenue growth.
Pre-IPO CanSino Biologics – 2022 Annual Results May Be Ugly as MCV4 Commercialization Hit a Snag
- CanSino Biologics Inc (6185 HK) disclosed plans to publicly list in Switzerland, but the story of the fourth dose of COVID-19 vaccine is difficult to boost its stock price/valuation.
- According to CanSino’s management,MCV4’s commercialization faced some challenges, which means 2022 annual performance may not be good. 2021 would probably be a high point of CanSino’s performance in recent years.
- Share price could pullback when 2022 annual report is released, which offers a better opportunity if investors want to go long, considering CanSino’s long-term investment value analyzed in prior insights.
GoDaddy Inc: Major Drivers, Financial Forecasts, DCF & Comparables Valuation, Key Risks (01/23)
- GoDaddy delivered a mixed set of results for the last quarter.
- However, it did manage an earnings beat which was largely a result of the robust consumer retention.
- This quarter, GoDaddy launched free SSL on almost all innovative web hosting plans in its major markets.
SunPower Corporation: Partnership With General Motors & Other Drivers
- SunPower delivered an all-around beat in the last quarter as the value of the company’s storage and solar systems continues to rise with the rise in utility rates.
- Consumer demand in the quarter continues to be quite strong and it added 23,1000 new customers this quarter which displays a persistent level of robust consumer demand for residential solar, particularly SunPower.
- We provide the stock of SunPower with an ‘Outperform’ rating and a revision in the target price.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
